+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

AR/VR based Healthcare Digital Marketing Service Providers Market, 2020-2030

  • PDF Icon

    Report

  • 190 Pages
  • June 2020
  • Region: Global
  • Roots Analysis
  • ID: 5136145
Description Jump to:

The advent of smartphones coupled with the easy accessibility of information on the internet has rendered it crucial for companies to establish a digital presence. As opposed to traditional strategies, digital marketing is not only cost-effective but offers several ancillary benefits, such as targeted outreach and data-driven output. In fact, a recent study stated that digital advertising is expected to account for around 50% of the overall global advertisement spend by 2021. However, the adoption of digital marketing solutions in the pharmaceutical industry has been stymied owing to various regulatory restrictions; presently, the healthcare industry accounts for only 2% of the US digital ad spend. Despite this, it is encouraging to note that over 85% of the patients in the US have access to digital and online resources to assist them in making informed healthcare decisions. Further, most of the individuals claim to use healthcare apps to track their diagnosed condition; therefore, a large amount of data is available for studying the trends associated with a particular indication. In addition, a recent study concluded that physicians are actively using different digital and social media platforms in order to make healthcare-related decisions, such as prescription of a particular drug. The aforementioned factors indicate that there is a growing need for pharma companies to increase their digital presence, through activity on social media and participation in online forums, in order to widen their reach to target the relevant customer segments.

Augmented reality (AR) and virtual reality (VR) technologies offer several advantages; examples include allowing patients to have a deeper understanding of their condition, ensuring effective communication by providing immersive experiences, assisting sales representatives to give quick and appealing product illustrations, and enabling individuals to assess the impact of various treatment options, through product demonstrations or use of virtual clinics. Estimates suggest that more than 60% of the consumers feel more engaged with a brand that offers them a VR experience; likewise, a similar percentage of US-based physicians are reported to be inclined to use such solutions for education and training purposes. The growing applications of AR/VR in the healthcare marketing sector have compelled various big pharma players to invest in such novel solutions and innovative strategies. We believe that stakeholders in the pharma industry that choose to adopt such technologies, in order to form engaging relationships with their consumers and ensure brand loyalty, are likely to be able to distinguish themselves from other industry stakeholders.

Scope of the Report

The ‘AR/VR based Healthcare Digital Marketing Service Providers, 2020-2030’ report features an extensive study of the current market landscape and future opportunities associated with the AR/VR based digital marketing industry in the healthcare domain. Amongst other elements, the report features:


  • A review of the current market landscape of companies offering AR/VR based digital marketing services, featuring type of technology (AR, VR, and MR), AR/VR specific services (video/content generation, website development, mobile application development and game development), additional digital marketing services (consulting, content marketing, customer relationship management, data analytics, marketing automation, product branding, quality assurance, SEO, SEM, social media marketing and training), information on the year of establishment, company size and location of headquarters.
  • An insightful 2X2 representation, highlighting the competitiveness analysis of digital marketing companies, taking into consideration supplier power (based on company size) and service strength (based on strength of service portfolio) of the companies.
  • Elaborate profiles of prominent digital marketing companies, featuring a brief overview of the company, its financial information (if available), recent developments, and an informed future outlook.
  • An analysis highlighting the potential strategic partners segregated on the basis of their likelihood of entering into a collaboration with digital marketing companies. The analysis takes into consideration multiple relevant parameters, such as number of trials, therapeutic area, geographical footprint, and company size.
  • An analysis of various AR/VR based digital marketing initiatives of big pharma players (shortlisted based on the extent of activity in this domain), based on multiple parameters, such as the year of initiative, type of initiative, type of application area and type of solution. In addition, leading players and leading partners have been highlighted based on the number of initiatives.
  • A case study on recent use cases, wherein various digital marketing strategies have been adopted by pharmaceutical/healthcare players, highlighting different business needs of such players and key takeaways of the solutions provided by the digital marketing companies.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future opportunity within the market. Based on several parameters, such as digital marketing spend within the pharma industry, the extent of adoption of AR/VR technologies and expected annual growth rate, we have provided an informed estimate of the likely evolution of the market, in the mid to long term, for the period 2020-2030. The chapter features the likely distribution of the future opportunity across [A] type of technology (AR, VR and MR), [B] type of product (Hardware and Software), [C] end-user (Small and Mid-sized Pharma Companies, and Large Pharma Companies) and [D] key geographical regions (North America, Europe, Asia-Pacific and rest of the world).

In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base, and optimistic tracks of the market’s evolution. The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain. In addition, the report features detailed transcripts of interviews held with the following individuals (in alphabetical order of company names):


  • Dhananjay Arora (Founder and CEO, Kwebmaker)
  • Pritam Sahu (Director, Unanimity Information & Technology)

All actual figures have been sourced and analyzed from publicly available information forums. Financial figures mentioned in this report are in USD, unless otherwise specified.


Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Key Challenges in Pharmaceutical Marketing
3.2.1. Need for Product Differentiation
3.2.2. Growing Demand for Patient Centric Healthcare
3.2.3. Lack of Standard Performance Metrics
3.2.4. Need for Scientific Communication
3.3. Importance of Digital Marketing
3.4. Popular Digital Marketing Strategies
3.4.1. Social Media Marketing
3.4.2. Content Marketing Strategy
3.4.3. Marketing Automation
3.4.4. Search Engine Optimization and Marketing
3.4.5. Artificial Intelligence based Marketing
3.5. Use of Augmented Reality and Virtual Reality (AR/VR) in Pharmaceutical Digital Marketing
3.6. Growth Constraints in AR/VR Industry
3.7. Future Perspectives
4. AR/VR BASED HEALTHCARE DIGITAL MARKETING COMPANIES: CURRENT MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Digital Marketing in Pharmaceutical Industry: Overall Market
4.2.1. Analysis by Type of Technology
4.2.2. Analysis by AR/VR based Services Offered
4.2.3. Analysis by Type of Digital Marketing Services Offered
4.2.4. Analysis by Secondary Marketing Services Offered
4.2.5. Analysis by Year of Establishment
4.2.6. Analysis by Company Size
4.2.7. Analysis by Geographical Location
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology and Key Parameters
5.2.1. Competitiveness Analysis: AR/VR based Digital Marketing Service Providers based in North America
5.2.2. Competitiveness Analysis: AR/VR based Digital Marketing Service Providers based in Europe
5.2.3. Competitiveness Analysis: AR/VR based Digital Marketing Service Providers based in Asia-Pacific
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. ARworks
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook
6.3. CG Life
6.3.1. Company Overview
6.3.2. Recent Developments and Future Outlook
6.4. CubeZoo
6.4.1. Company Overview
6.4.2. Recent Developments and Future Outlook
6. 5. Impact XM
6. 5.1. Company Overview
6. 5.2. Recent Developments and Future Outlook
6.6. INVIVO Communications
6.6.1. Company overview
6.6.2. Recent Developments and Future Outlook
6.7. Mindgrub
6.7.1. Company Overview
6.7.2. Recent Developments and Future Outlook
6.8. Mirum
6.8.1. Company Overview
6.8.2. Recent Developments and Future Outlook
6.9. PIXACORE
6.9.1. Company Overview
6.9.2. Recent Developments and Future Outlook
6.10. Quast Media
6.10.1. Company Overview
6.10.2. Recent Developments and Future Outlook
6.11. Random42
6.11.1. Company Overview
6.11.2. Recent Developments and Future Outlook
6.12. Tipping Point Media
6.12.1. Company Overview
6.12.2. Recent Developments and Future Outlook
6.13. vStream
6.13.1. Company Overview
6.13.2. Recent Developments and Future Outlook
7. POTENTIAL STRATEGIC PARTNERS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Potential Strategic Partners for Digital Marketing Companies
7.3.1. Most Likely Partners
7.3.2. Likely Partners
7.3.3. Less Likely Partners
7.3.4. Least Likely Partners
8. DIGITAL MARKETING RELATED INITIATIVES OF BIG PHARMA PLAYERS
8.1. Chapter Overview
8.1.1. Analysis by Year
8.1.2. Analysis by Type of Initiative
8.1.3. Analysis by Type of Application Area
8.1.4. Analysis by Type of Solution
8.1.5. Leading Players: Analysis by Number of Initiatives
8.1.6. Leading Partners: Analysis by Number of Initiatives
9. CASE STUDY
9.1. Chapter Overview
9.2. Narola Infotech for Zocular
9.2.1. Narola Infotech
9.2.2. Zocular
9.2.3. Business Needs
9.2.4. Objectives Achieved and Solutions Provided
9.3. Viscira for Actelion
9.3.1. Viscira
9.3.2. Actelion
9.3.3. Business Needs
9.3.4. Objectives Achieved and Solutions Provided
9.4. SoftCover VR for LifeLabs
9.4.1. SoftCover VR
9.4.2. LifeLabs
9.4.3. Business Needs
9.4.4. Objectives Achieved and Solutions Provided
9.5. Virtual Reality Ireland for MISA
9.5.1. Virtual Reality Ireland
9.5.2. MISA
9.5.3. Business Needs
9.5.4. Objectives Achieved and Solutions Provided
9.6. ViitorCloud for vCura
9.6.1. ViitorCloud
9.6.2. vCura
9.6.3. Business Needs
9.6.4. Objectives Achieved and Solutions Provided
9.7. Kwebmaker for Lilavati Hospital
9.7.1. Kwebmaker
9.7.2. Lilavati Hospital
9.7.3. Business Needs
9.7.4. Objectives Achieved and Solutions Provided
9.8. Intermind for My Health Meter
9.8.1. Intermind
9.8.2. My Health Meter
9.8.3. Business Needs
9.8.4. Objectives Achieved and Solutions Provided
9.9. VR Vision for Providence Healthcare
9.9.1. VR Vision
9.9.2. Providence Healthcare
9.9.3. Business Needs
9.9.4. Objectives Achieved and Solutions Provided
9.10. CitrusBits for Zoetis
9.10.1. CitrusBits
9.10.2. Zoetis
9.10.3. Business Needs
9.10.4. Objectives Achieved and Solutions Provided
10. MARKET FORECAST
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Overall AR/VR based Digital Marketing Opportunity in Healthcare Industry, 2020-2030
10.4. AR/VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Type of Technology, 2020 and 2030
10.5. AR/VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Product, 2020 and 2030
10.6. AR/VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by End-User, 2020 and 2030
10.7. AR/VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Key Geographical Regions, 2020 and 2030
10.7.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America, 2020-2030
10.7.1.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Distribution by Type of Technology, 2020 and 2030
10.7.1.1.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of AR-based Services, 2020 and 2030
10.7.1.1.2. AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of VR based Services, 2020-2030
10.7.1.1.3. AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Mixed Reality (MR) based Services, 2020 and 2030
10.7.1.2. AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Distribution by Type of Product, 2020 and 2030
10.7.1.2.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Hardware Products, 2020-2030
10.7.1.2.2. AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Software Products, 2020-2030
10.7.2. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe, 2020-2030
10.7.2.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Distribution by Type of Technology, 2020-2030
10.7.2.1.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of AR-based Services, 2020-2030
10.7.2.1.2. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of VR based Services, 2020-2030
10.7.2.1.3. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of AR-based Services, 2020-2030
10.7.2.2. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Distribution by Type of Product, 2020 and 2030
10.7.2.2.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: share of Hardware Products, 2020-2030
10.7.2.2.2. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of Software Products, 2020-2030
10.7.3. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific, 2020-2030
10.7.3.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Distribution by Type of Technology, 2020 and 2030
10.7.3.1.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of AR-based Services, 2020 and 2030
10.7.3.1.2. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of VR based Services, 2020-2030
10.7.3.1.3. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of MR based Services, 2020 and 2030
10.7.3.2. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Distribution by Type of Product, 2020 and 2030
10.7.3.2.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of Hardware Products, 2020-2030
10.7.3.2.2. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of Software Products, 2020-2030
10.7.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World, 2020-2030
10.7.1.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Distribution by Type of Technology, 2020 and 2030
10.7.1.1.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of AR-based Services, 2020 and 2030
10.7.1.1.2. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of VR based Services. 2020-2030
10.7.1.1.3. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of MR based Services, 2020 and 2030
10.7.1.2. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Distribution by Type of Product, 2020 and 2030
10.7.1.2.1. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of Hardware Products, 2020-2030
10.7.1.2.2. AR/VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of Software Products, 2020-2030
11. EXECUTIVE INSIGHTS
11.1. Chapter Overview
11.2. Unanimity Information & Technology
11.2.1. Interview Transcript: Pritam Sahu, Director, Unanimity Information & Technology
11.3. Kwebmaker
11.3.1. Interview Transcript: Dhananjay Arora, Founder, and CEO, Kwebmaker
12. CONCLUSION13. APPENDIX 1: TABULATED DATA
List Of Figures
Figure 3.1 Digital Advertising Spend: Distribution by Type of Industry
Figure 3.2 Challenges in Pharmaceutical Marketing
Figure 3.3 Popular Digital Marketing Strategies
Figure 3.4 Social Media Marketing Channels
Figure 3.5 Search Engine Ranking Factors
Figure 3.6 Benefits of AI in Digital Marketing
Figure 4.1 AR/VR based Digital Marketing Service Providers: Distribution by Type of Technology
Figure 4.2 AR/VR based Digital Marketing Service Providers: Distribution by AR/VR based Services Offered
Figure 4.3 AR/VR based Digital Marketing Service Providers: Distribution by Type of Digital Marketing Services Offered
Figure 4.4 AR/VR based Digital Marketing Service Providers: Distribution by Secondary Marketing Services Offered
Figure 4.5 AR/VR based Digital Marketing Service Providers: Distribution by Year of Establishment.
Figure 4.6 AR/VR based Digital Marketing Service Providers: Distribution by Company Size
Figure 4.7 AR/VR based Digital Marketing Service Providers: Distribution by Geographical Location
Figure 5.1 Competitiveness Analysis: AR/VR based Digital Marketing Service Providers based in North America
Figure 5.2 Competitiveness Analysis: AR/VR based Digital Marketing Service Providers based in Europe
Figure 5.3 Competitiveness Analysis: AR/VR based Digital Marketing Service Providers based in Asia-Pacific
Figure 8.1 Big Pharma Initiatives: Distribution by Year
Figure 8.2 Big Pharma Initiatives: Distribution by Type of Initiative
Figure 8.3 Big Pharma Initiatives: Distribution by Type of Application Area
Figure 8.4 Big Pharma Initiatives: Heat Map Analysis by Type of Application Area
Figure 8.5 Big Pharma Initiatives: Distribution by Type of Solution
Figure 8.6 Big Pharma Initiatives: Heat Map Analysis by Type of Solution
Figure 8.7 Leading Players: Distribution by Number of Initiatives
Figure 8.8 Leading Partners: Distribution by Number of Initiatives
Figure 10.1 Overall AR/VR based Digital Marketing Opportunity in Healthcare Industry, 2020-2030 (USD Billion)
Figure 10.2 AR/VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Type of Technology, 2020 and 2030 (USD Billion)
Figure 10.3 AR/VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Product, 2020 and 2030 (USD Billion)
Figure 10.4 AR/VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by End-User, 2020 and 2030 (USD Billion)
Figure 10.5 AR/VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Key Geographical Region, 2020 and 2030 (USD Billion)
Figure 10.6 AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America, 2020-2030 (USD Billion)
Figure 10.7 AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of AR-based Services, 2020-2030 (USD Billion)
Figure 10.8 AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of VR based Services, 2020-2030 (USD Billion)
Figure 10.9 AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of MR based Services, 2020-2030 (USD Billion)
Figure 10.10 AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Hardware Products, 2020-2030 (USD Billion)
Figure 10.11 AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Software Products, 2020-2030 (USD Billion)
Figure 10.12 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe, 2020-2030 (USD Billion)
Figure 10.13 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of AR-based Services, 2020-2030 (USD Billion)
Figure 10.14 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of VR based Services, 2020-2030 (USD Billion)
Figure 10.15 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of MR based Services, 2020-2030 (USD Billion)
Figure 10.16 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of Hardware Products, 2020-2030 (USD Billion)
Figure 10.17 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of Software Products, 2020-2030 (USD Billion)
Figure 10.18 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia Pacific, 2020-2030 (USD Billion)
Figure 10.19 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia Pacific: Share of AR-based Services, 2020-2030 (USD Billion)
Figure 10.20 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia Pacific: Share of VR based Services, 2020-2030 (USD Billion)
Figure 10.21 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia Pacific: Share of MR based Services, 2020-2030 (USD Billion)
Figure 10.22 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia Pacific: Share of Hardware Products, 2020-2030 (USD Billion)
Figure 10.23 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia Pacific: Share of Software Products, 2020-2030 (USD Billion)
List Of Tables
Table 4.1 AR/VR based Digital Marketing Service Providers: Information on Type of Technology and Affiliated Services Offered
Table 4.2 AR/VR based Digital Marketing Service Providers: Information on Type of Digital Marketing Services Offered
Table 4.3 AR/VR based Digital Marketing Service Providers: Information on Secondary Marketing Services Offered
Table 4.4 AR/VR based Digital Marketing Service Providers: List of Companies
Table 6.1 AR works: Company Snapshot
Table 6.2 CG Life: Company Snapshot
Table 6.3 CG Life: Recent Developments and Future Outlook
Table 6.4 CubeZoo: Company Snapshot
Table 6.5 Impact XM: Company Snapshot
Table 6.6 Impact XM: Recent Developments and Future Outlook
Table 6.7 INVIVO Communications: Company Snapshot
Table 6.8 INVIVO Communications: Recent Developments and Future Outlook
Table 6.9 Mindgrub: Company Snapshot
Table 6.10 Mindgrub: Recent Developments and Future Outlook
Table 6.11 Mirum: Company Snapshot
Table 6.12 Mirum: Recent Developments and Future Outlook
Table 6.13 PIXACORE: Company Snapshot
Table 6.14 PIXACORE: Recent Developments and Future Outlook
Table 6.15 Quast Media: Company Snapshot
Table 6.16 Random42: Company Snapshot
Table 6.17 Rando m42: Recent Developments and Future Outlook
Table 6.18 Tipping Point Media: Company Snapshot
Table 6.19 vStream: Company Snapshot
Table 6.20 vStream: Recent Developments and Future Outlook
Table 7.1 Most Likely Partners
Table 7.2 Likely Partners
Table 7.3 Less Likely Partners
Table 7.4 Least Likely Partners
Table 13.1 AR/VR based Digital Marketing Service Providers: Distribution by Type of Technology
Table 13.2 AR/VR based Digital Marketing Service Providers: Distribution by AR/VR based Services Offered
Table 13.3 AR/VR based Digital Marketing Service Providers: Distribution by Digital Marketing Services Offered
Table 13.4 AR/VR based Digital Marketing Service Providers: Distribution by Secondary Marketing Services Offered
Table 13.5 AR/VR based Digital Marketing Service Providers: Distribution by Year of Establishment
Table 13.6 AR/VR based Digital Marketing Service Providers: Distribution by Company Size
Table 13.7 AR/VR based Digital Marketing Service Providers: Distribution by Geographical Location
Table 13.8 Big Pharma Initiatives: Distribution by Year
Table 13.9 Big Pharma Initiatives: Distribution by Type of Initiative
Table 13.10 Big Pharma Initiatives: Distribution by Type of Application Area
Table 13.11 Big Pharma Initiatives: Distribution by Type of Solution
Table 13.12 Leading Players: Analysis by Number of Initiatives
Table 13.13 Leading Partners: Analysis by Number of Initiatives
Table 13.14 Overall AR/VR based Digital Marketing Opportunity in Healthcare Industry, 2020-2030 (USD Billion)
Table 13.15 AR/VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Type of Technology, 2020 and 2030 (USD Billion)
Table 13.16 AR/VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Product, 2020 and 2030 (USD Billion)
Table 13.17 AR/VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by End-User, 2020 and 2030 (USD Billion)
Table 13.18 AR/VR based Digital Marketing Opportunity in Healthcare Industry: Distribution by Key Geographical Region, 2020 and 2030 (USD Billion)
Table 13.19 AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America, 2020-2030 (USD Billion)
Table 13.20 AR/VR based Digital Marketing Opportunity in Healthcare Industry: in North America: Share of AR-based Services, 2020-2030 (USD Billion)
Table 13.21 AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of VR based Services, 2020-2030 (USD Billion)
Table 13.22 AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of MR based Services, 2020-2030 (USD Billion)
Table 13.23 AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Hardware Products, 2020-2030 (USD Billion)
Table 13.24 AR/VR based Digital Marketing Opportunity in Healthcare Industry in North America: Share of Software Products, 2020-2030 (USD Billion)
Table 13.25 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe, 2020-2030 (USD Billion)
Table 13.26 AR/VR based Digital Marketing Opportunity in Healthcare Industry: in Europe: Share of AR-based Services, 2020-2030 (USD Billion)
Table 13.27 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of VR based Services, 2020-2030 (USD Billion)
Table 13.28 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of MR based Services, 2020-2030 (USD Billion)
Table 13.29 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of Hardware Products, 2020-2030 (USD Billion)
Table 13.30 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Europe: Share of Software Products, 2020-2030 (USD Billion)
Table 13.31 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific, 2020-2030 (USD Billion)
Table 13.32 AR/VR based Digital Marketing Opportunity in Healthcare Industry: in Asia-Pacific: Share of AR-based Services, 2020-2030 (USD Billion)
Table 13.33 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of VR based Services, 2020-2030 (USD Billion)
Table 13.34 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of MR based Services, 2020-2030 (USD Billion)
Table 13.35 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of Hardware Products, 2020-2030 (USD Billion)
Table 13.36 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Asia-Pacific: Share of Software Products, 2020-2030 (USD Billion)
Table 13.37 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World, 2020-2030 (USD Billion)
Table 13.38 AR/VR based Digital Marketing Opportunity in Healthcare Industry: in Rest of the World: Share of AR-based Services, 2020-2030 (USD Billion)
Table 13.39 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of VR based Services, 2020-2030 (USD Billion)
Table 13.40 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of MR based Services, 2020-2030 (USD Billion)
Table 13.41 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of Hardware Products, 2020-2030 (USD Billion)
Table 13.42 AR/VR based Digital Marketing Opportunity in Healthcare Industry in Rest of the World: Share of Software Products, 2020-2030 (USD Billion)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3TI Solutions
  • 4D Pharma
  • 4Experience
  • [x]cube LABS
  • A101
  • A2 Healthcare Taiwan
  • A2 VR
  • AbbVie
  • Abivax
  • Acceleron Pharma
  • Acerta Pharma
  • Achillion Pharmaceuticals
  • Aclaris Therapeutics
  • Acodez
  • Actelion
  • ADC Therapeutics
  • ADSMN Interactive
  • Aduro Biotech
  • Agendia
  • Agenus
  • AGILE Infoways
  • Agios Pharmaceuticals
  • AIO-Studien
  • Akari Therapeutics
  • Akeso Pharmaceuticals
  • Alfasigma
  • Alkahest
  • Allakos
  • Allergan
  • Alnylam Pharmaceuticals
  • Altor BioScience
  • Amarex Clinical Research
  • Amazon Web Services
  • Amgen
  • Amplyx Pharmaceuticals
  • AnaptysBio
  • Anavex Australia
  • AnewPharma
  • Antengene
  • Apexigen
  • Apices Soluciones
  • Appingine
  • Appnings Software Solutions
  • AppsChopper
  • Aprea Therapeutics
  • Aptinyx
  • Aravive
  • Arbeitsgemeinschaft medikamentöse Tumortherapie
  • Arccus
  • Arcutis Biotherapeutics
  • Arena Pharmaceuticals
  • argenx
  • Array BioPharma
  • Arrowhead Pharmaceuticals
  • ARworks
  • Assaf Harofeh Medical Center
  • Astellas Pharma
  • Astex Pharmaceuticals
  • AstraZeneca
  • Atlantic Exhibits
  • Atrium Health
  • Audentes Therapeutics
  • Augmentastic
  • Augmented Scalla Matta
  • Augmently
  • Aurora Pharmaceutical
  • Autolus
  • Auxano Global Services
  • AVEO Pharmaceuticals
  • Azura Ophthalmics
  • Balance Digital Media Studios
  • Bannerflow
  • Bausch Health
  • Bavarian Nordic
  • Bayer
  • BeiGene
  • Bellerophon Therapeutics
  • Bellicum Pharmaceuticals
  • BenHealth Biopharmaceutical
  • BerGenBio
  • Betta Pharmaceuticals
  • BIOCAD
  • Biofabri
  • Biogen
  • Biohaven Pharmaceuticals
  • BioLite
  • BioMarin Pharmaceutical
  • BioMimetix
  • BioNTech
  • Blue Earth Diagnostics
  • Blueprint Medicines
  • Boehringer Ingelheim
  • Boston Biomedical
  • Bracco Diagnostics
  • Breath of Life International Pharma
  • BrickSimple
  • Bristol-Myers Squibb
  • Calithera Biosciences
  • Cancer Insight
  • Canopy Health Innovations
  • CAS Lamvac Biotech
  • Catalysis
  • CCH Marketing
  • Celgene
  • Celldex Therapeutics
  • CG Life
  • ChemoCentryx
  • Chia Tai Tianqing Pharmaceutical
  • Chiesi Farmaceutici
  • Chipscreen Biosciences
  • Chong Kun Dang Pharmaceutical
  • Chongqing Precision Biotech
  • CHRP-India
  • CitrusBits
  • Clavax
  • Clene Nanomedicine
  • Clevbrain Technologies
  • Clinical Trial Center North
  • Clovis Oncology
  • Codebrik
  • Collaborative Medicinal Development
  • Complexa
  • Concert Pharmaceuticals
  • Constellation Pharmaceuticals
  • Corcept Therapeutics
  • Corvecto
  • Cosmo Pharmaceuticals
  • Covance
  • Cramer
  • Creatinno Tech
  • Creative Hub
  • Cree
  • Crinetics Pharmaceuticals
  • CRISPR Therapeutics
  • Crownpeak Partner Network
  • CSL Behring
  • CSPC Ouyi Pharmaceutical
  • CSPC ZhongQi Pharmaceutical Technology
  • CStone Pharmaceuticals
  • CTI BioPharma
  • CTI Clinical Trial and Consulting Services
  • CubeZoo
  • Cumberland Pharmaceuticals
  • Custom Learning Designs
  • Cygnet Infotech
  • CytomX Therapeutics
  • Da Vinci Media Production House
  • Daiichi Sankyo
  • Dascena
  • data.world
  • DealTech
  • Debiopharm International
  • Diamyd Medical
  • Digital Glare
  • Digital Jalebi
  • Digital Media HQ
  • DigiTrends
  • Divison 6
  • Divwy Technologies
  • Dizal Pharmaceutical
  • eFFECTOR Therapeutics
  • Eisai
  • Elevar Therapeutics
  • Eli Lilly
  • Eloxx Pharmaceuticals
  • EMD Serono
  • EmeraMed
  • Emergent BioSolutions
  • Empathetic Media
  • EMS
  • Endive Software
  • Energenesis Biomedical
  • Eon Reality
  • Equations Digital
  • Ethosh
  • ExCellThera
  • Exelixis
  • ExpertsFromIndia
  • Fake Production
  • Ferring Pharmaceuticals
  • FGK Clinical Research
  • Fluper
  • Focusteck
  • Folio3
  • FORMA Therapeutics
  • Foundation Medicine
  • Fulcrum Therapeutics
  • G1 Therapeutics
  • Galapagos
  • Geekstack
  • Genentech
  • General Electric
  • GeneScience Pharmaceuticals
  • Genesis Technologies
  • Genexine
  • Genmab
  • Genor Biopharma
  • Genuine
  • Gilead Sciences
  • GlaxoSmithKline
  • Golden Biotechnology
  • Gossamer Bio
  • Granzer Regulatory Consulting & Services
  • Green Cross International
  • Guangzhou Anjie Biomedical Technology
  • Gwo Xi Stem Cell Applied Technology
  • GWT-TUD
  • Halozyme Therapeutics
  • Hamilton Health Sciences
  • Hanmi Pharmaceutical
  • Health Decisions
  • Helsinn Healthcare
  • Herantis Pharma
  • Heron Therapeutics
  • HighTide Biopharmaceutical
  • Hope Biosciences
  • Hope Infotech
  • HQSoftware
  • HTC
  • HunterTech
  • Hutchison MediPharma
  • Hyperlink InfoSystem
  • I-Mab Biopharma
  • ibiixo Technologies
  • Ichnos Sciences
  • ILTOO Pharma
  • Imaginate
  • Imago BioSciences
  • Immunitor
  • Immunocore
  • ImmunoGen
  • Immunomedics
  • Immunovant
  • Impact XM
  • IMV
  • In2Real
  • Incyte
  • Infinito VFX
  • InflaRx
  • InnoCare Pharma
  • Innovent Biologics
  • Inovio Pharmaceuticals
  • INSYS Therapeutics
  • Intermind
  • IntraBio
  • Invivo
  • IO Biotech
  • iObeya
  • Ionis Pharmaceuticals
  • Iovance Biotherapeutics
  • Ipsen
  • iQlance
  • IQVIA
  • Irish Heart Foundation
  • Janssen Pharmaceuticals
  • Jash Entertainment
  • Jazz Pharmaceuticals
  • JCR Pharmaceuticals
  • Jiangsu Alphamab Biopharmaceuticals
  • Jiangsu Hengrui Medicine
  • Johnson & Johnson
  • JPLoft
  • Julius Clinical
  • Juno Therapeutics
  • Kadmon
  • Kanda
  • Kartos Therapeutics
  • Karyopharm Therapeutics
  • KENWAVES
  • Kezar Life Sciences
  • KGK Science
  • Khora Virtual Reality
  • Kiniksa Pharmaceuticals
  • Kissei Pharmaceutical
  • Kwebmaker
  • Kyowa Kirin
  • Laduma
  • Lallemand Health Solutions
  • LEAP
  • Leap Therapeutics
  • Lee's Pharmaceutical
  • leftchannel
  • LEO Pharma
  • LG Chem
  • Longeveron
  • LotzAp
  • Loxo Oncology
  • Luminary
  • MacroGenics
  • Mallinckrodt
  • Marinus Pharmaceuticals
  • Maruho
  • Matterhorn
  • Mayo Clinic
  • McCann Health
  • McDAY
  • Media Horizon
  • MediciNova
  • MedImmune
  • MEDIPOST
  • Medpace
  • MedPacto
  • MedSIR
  • Medy-Tox
  • MeiraGTx
  • Memat Digi
  • Merck
  • Mereo BioPharma
  • MFAR
  • Microsoft
  • Millennium Pharmaceuticals
  • Miltenyi Biotec
  • Mindgrub
  • Mindtree
  • miRagen Therapeutics
  • Mirati Therapeutics
  • Mirum
  • Miyens
  • mld digits
  • Moderna
  • Momenta Pharmaceuticals
  • MultiVir
  • Mutual Mobile
  • MV3
  • MyoKardia
  • NanOlogy
  • Nanopixel
  • NantKwest
  • Narola Infotech
  • NCodeTechnologies
  • Nektar Therapeutics
  • Neurocrine Biosciences
  • NeuroRx
  • Newish Technology
  • NEXT/NOW
  • Nobelpharma
  • Northwell Health
  • Novartis
  • Novo Nordisk
  • Novocure
  • NYU Langone Health
  • OBI Pharma
  • Oncoceutics
  • Oncology Venture
  • Oncopeptides
  • OncoSec Medical
  • OneProsper International
  • Ono Pharmaceutical
  • Oramed
  • Orchard Therapeutics
  • Orion
  • Otsuka Pharmaceutical
  • Ovid Therapeutics
  • Panther Studio
  • Parexel
  • Peloton Therapeutics
  • Pfizer
  • Pharmacyclics
  • PharmaMar
  • PhaseBio Pharmaceuticals
  • PhytoHealth
  • Pierre Fabre
  • Pivotal
  • PIXACORE
  • Polygon Medical Animation
  • PPD
  • PRA Health Sciences
  • Precision BioSciences
  • PrECOG
  • Preksh
  • Progenics Pharmaceuticals
  • ProQR Therapeutics
  • Protagonist Therapeutics
  • Providence Health & Services
  • PRP Concepts
  • Pulmocide
  • Pulmotect
  • Puma Biotechnology
  • Qilu Pharmaceutical
  • Quast Media
  • R-Pharm
  • Ra Pharmaceuticals
  • Random42
  • Reality Garage
  • Red Apple Technologies
  • RedRock Digimark
  • Regeneron Pharmaceuticals
  • REGENXBIO
  • Reistone Biopharma
  • RemeGen
  • Revance Therapeutics
  • RHEACELL
  • Rhizen Pharmaceuticals
  • Rhythm Pharmaceuticals
  • Roche
  • Rocket Pharmaceuticals
  • Samsung Medical Center
  • Samumed
  • Sanaria
  • Sangamo Therapeutics
  • Sanofi
  • Santen Pharmaceutical
  • Sarepta Therapeutics
  • Scientimed
  • Scintilla Kreations
  • Sclnow Biotechnology
  • SCRI Development Innovations
  • Seattle Genetics
  • Seehash Softwares
  • SENSE-R
  • Service Monkey
  • Servier
  • Shenzhen BinDeBio
  • Shionogi
  • Shire
  • Simulanis
  • Sinocelltech
  • SITSL
  • SM Digital Partners
  • SoftCover Virtual Reality
  • Softweb Solutions
  • Spectrum Pharmaceuticals
  • Spring Bank Pharmaceuticals
  • SpringWorks Therapeutics
  • SSS International Clinical Research
  • Stryker
  • Studio 27 Creative Media Works
  • Subvrsive
  • Sun Pharma Advanced Research
  • Sunovion
  • Sunshine Lake Pharma
  • Suzhou Zelgen Biopharmaceuticals
  • SVAP Infotech
  • Swedish Orphan Biovitrum
  • Swiss Tomato
  • Syndax Pharmaceuticals
  • Syneos Health
  • Syntax for Science
  • TA Digital
  • Taiho Oncology
  • Taiwan Liposome Company
  • Takara Bio
  • Takeda
  • Talking Tree Creative
  • Target Health
  • Teads
  • Tech Data
  • Techno’s Tech Solutions
  • TESARO
  • TestByNet
  • Teva Pharmaceuticals
  • TG Therapeutics
  • The Antialias
  • The Emmes Company
  • The Market Element
  • The NineHertz
  • The Parallel
  • Themis Bioscience
  • Theradex Oncology
  • Theravance Biopharma
  • Thread Solutions
  • Tianhe Stem Cell Biotechnologies
  • TICEBA
  • Tilray
  • Tipping Point Media
  • Tolerion
  • Tolero Pharmaceuticals
  • Transgene
  • Trium Analysis Online
  • Trovagene
  • Tufts Medical Center
  • Turning Point Therapeutics
  • TYME Technologies
  • UCB
  • Ultimate Medical Academy
  • Ultragenyx Pharmaceutical
  • Unanimity Information & Technology
  • United BioPharma
  • United Therapeutics
  • University Medical Center  Utrecht
  • University of Toronto
  • US Biotest
  • US WorldMeds
  • Vaccitech
  • Variance InfoTech
  • Vedanta Biosciences
  • Verastem Oncology
  • Vertex Pharmaceuticals
  • Viela Bio
  • ViitorCloud Technologies
  • Virtual Reality Ireland
  • Viscira
  • Vistaar Digital Communications
  • Visualise
  • VR Vision
  • vStream
  • Warschawski
  • Weber Shandwick
  • WebZino
  • WETFY BRAND SOLUTIONS
  • WordPress
  • Xeris Pharmaceuticals
  • Xynomic Pharmaceuticals
  • Y-mAbs Therapeutics
  • YouVisit
  • Zai Lab
  • Zumoko
  • Zurich University of Applied Sciences
  • Zydus Cadila

Methodology

 

 

Loading
LOADING...

Related Topics

Related Reports

AR/VR Display Market by Technology, Device, Display Technology, End User, Application - Global Forecast 2025-2030 - Product Image

AR/VR Display Market by Technology, Device, Display Technology, End User, Application - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
AR & VR Software Market by Type, Platform, Software Type, Deployment, End-User - Global Forecast 2025-2030 - Product Image

AR & VR Software Market by Type, Platform, Software Type, Deployment, End-User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
AR/VR Medical Simulation Global Market Report 2024 - Product Image

AR/VR Medical Simulation Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Virtual Reality (VR) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Virtual Reality (VR) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 153 Pages
  • Global
From
Metaverse Market Size, Share & Trends Analysis Report By Product (Software, Services), By Platform (Desktop, Mobile), By Technology (VR & AR, Mixed Reality), By Application (Gaming, Online Shopping), By End-user, And Segment Forecasts, 2024 - 2030 - Product Image

Metaverse Market Size, Share & Trends Analysis Report By Product (Software, Services), By Platform (Desktop, Mobile), By Technology (VR & AR, Mixed Reality), By Application (Gaming, Online Shopping), By End-user, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.